Effects of Efonidipine Hydrochloride on Renal Arteriolar Diameters in Spontaneously Hypertensive Rats.

  • NAKAMURA Masuhisa
    Division of Pharmacology, Osaka University of Pharmaceutical Sciences
  • NOTOYA Mitsuru
    Shionogi Research Laboratories, Shionogi & Co., Ltd.
  • KOHDA Yuka
    Division of Pharmacology, Osaka University of Pharmaceutical Sciences
  • YAMASHITA Junji
    Division of Pharmacology, Osaka University of Pharmaceutical Sciences
  • TAKASHITA Yuko
    Division of Pharmacology, Osaka University of Pharmaceutical Sciences
  • GEMBA Munekazu
    Division of Pharmacology, Osaka University of Pharmaceutical Sciences

この論文をさがす

抄録

Efonidipine, a calcium antagonist, has been reported to dilate not only afferent but also efferent arterioles, thereby reducing glomerular hydrostatic pressure. We investigated the effect of chronic treatment with efonidipine or lisinopril on the afferent and efferent arteriolar diameters by the vascular cast technique. Four-week-old spontaneously hypertensive rats (SHR) were divided into three groups: untreated, efonidipine (25 mg/kg/day)-treated, and lisinopril (3 mg/kg/day)-treated. At 22 weeks of age, the renal vasculatures were fixed at the maximally dilated condition. The morphometrical measurements showed that the treatments with efonidipine and lisinopril caused structural alteration of the vasculature, resulting in significantly greater efferent arteriolar diameters than in untreated SHR. In addition, lisinopril-treated rats had wider afferent lumina. The renoprotective effect of efonidipine and lisinopril might be partly due to the structurally larger efferent arteriolar lumen. (Hypertens Res 2002; 25: 751-755)

収録刊行物

参考文献 (42)*注記

もっと見る

詳細情報

問題の指摘

ページトップへ